Hormone Therapy Current Events | Hormone Therapy News | 4
|
| Page
4 of
53 |
1057 Results |
|
|
|
Sort By:
Page Views | Date |
Study links obesity to elevated risk of ovarian cancer
A new epidemiological study has found that among women who have never used menopausal hormone therapy, obese women are at an increased risk of developing ovarian cancer compared with women of normal weight. view more (2009-01-05)
New research may explain why some who receive growth hormone therapy develop colon polyps
The use of growth hormone therapy has been linked in some people to the development of colon polyps, a possible precursor to colorectal cancer - but medical researchers have debated the extent of a cancer risk. view more (2006-04-10)
Predicting growth hormone treatment success
Growth hormone treatments work better on some children than on others, but judging which candidates will gain those vital inches in height is no simple task. view more (2007-12-13)
Brain plays key role in diabetes therapy
The brain plays a major role in the ability of insulin therapy to lower blood sugar in animals with diabetes. view more (2006-01-11)
Botanicals have no effect on hot flashes or cognition: Study
Two studies conducted by researchers at the University of Illinois at Chicago and Northwestern University have found that commonly used botanicals do not have an effect on hot flashes or on cognitive function in menopausal women. view more (2009-08-07)
Combined HRT increases risk of lobular breast cancer fourfold after just 3 years of use
Postmenopausal women who take combined estrogen/progestin hormone-replacement therapy for three years or more face a fourfold increased risk of developing various forms of lobular breast cancer, according to new findings by researchers at Fred Hutchinson Cancer Research Center. view more (2008-01-15)
Colon cancer a disease of hormone deficiency, Jefferson team finds
Researchers at the Kimmel Cancer Center at Jefferson in Philadelphia have found new evidence suggesting that colon cancer is actually a disease of missing hormones that could potentially be treated by hormone replacement therapy. view more (2007-08-01)
1 in 5 early-stage breast cancer patients may not follow hormonal therapy plan
Postmenopausal women with early-stage, hormone-sensitive breast cancer have a lower risk of disease recurrence when their treatment includes a new class of hormone therapy drugs, yet one out five women prescribed the drugs may not take them regularly. view more (2006-12-18)
New drug lets thyroid cancer patients avoid nasty side effects during treatment
A multicenter international study, including Johns Hopkins, has found that after surgery for thyroid cancer, giving genetically engineered human thyroid-stimulating hormone (rhTSH) before radioiodine treatment avoids the previous need to stop thyroid replacement therapy and the miserable side effects that go with it. view more (2006-01-10)
Study of early estrogen's effect on heart disease similar to WHI findings
Researchers in The Department of Obstetrics, Gynecology & Reproductive Sciences at Yale have launched the Kronos Early Estrogen Prevention Study (KEEPS), which will further understanding of the possible beneficial effects on the heart and arteries and/or quality of life in recently menopausal women. view more (2006-03-01)
NEW TEST FOR DOPING IN RACEHORSES
Scientists from Britain, Australia and South Africa have collaborated to develop a new test for drug abuse in racehorses. Use of growth hormone doping is worrying both horse racing and athletics authorities. Now new work, presented at the British Endocrine Societies annual meeting in Birmingham, may prevent cheating in horse racing, as well as... view more... (2000-03-07)
Cancer risk slightly higher for women in discontinued hormone treatment trial
A follow up study of participants in the Women's Health Initiative (WHI) clinical trial led by a University of North Carolina at Chapel Hill researcher has found that women who were taking the combined hormone therapy of estrogen plus progestin may have an increased risk of cancer since the intervention was stopped, compared to participants in the... view more... (2008-03-05)
Blocking protein kills prostate cancer cells, inhibits tumor growth, Jefferson scientists find
Researchers at Jefferson's Kimmel Cancer Center in Philadelphia have shown that they can effectively kill prostate cancer cells in both the laboratory and in experimental animal models by blocking a signaling protein that is key to the cancer's growth. view more (2008-02-28)
Decision aids help patients choose best treatment options
Interactive decision aids improves patient knowledge and can help patients play a more active part in making decisions about their treatment, suggest two studies in this week's BMJ. In the first study, 205 women in the UK considering hormone replacement treatment were randomly given either normal clinical care or a computer-based interactive... view more... (2001-08-29)
Naturally produced estrogen may protect women from Parkinson's disease
Women who have more years of fertility (the time from first menstruation to menopause) have a lower risk of developing Parkinson's disease than women with fewer years, according to a large, new study by researchers at Albert Einstein College of Medicine of Yeshiva University. view more (2009-02-26)
Combined Treatment Approach Increases Survival In Prostate Cancer
New study shows combination of radiotherapy and hormone therapy extends life expectancy. view more (2005-04-04)
Growth hormone to boost athletic performance risks diabetes
Use of growth hormone to boost athletic performance can lead to diabetes, reports a study published ahead of print in the British Journal of Sports Medicine. view more (2007-02-26)
Fitness counteracts cognitive decline from hormone-replacement therapy
Women pondering hormone-replacement therapy also should consider regular exercise. A new study at the University of Illinois at Urbana-Champaign suggests that being physically fit offsets cognitive declines attributed to long-term therapy. view more (2006-01-25)
Breast Cancer Drug Shows Promise for Treating, Preventing Progestin-Dependent Tumors
Recent studies suggest that human breast cancer risk is increased by outside exposure to the hormone progestin, such as during hormone replacement therapy. Now, a University of Missouri study suggests that PRIMA-1, a small molecule drug that targets the most common mutated gene, p53, in human cancer cells, has potential as a novel chemotherapeutic... view more... (2009-01-29)
Rapidly rising PSA before treatment is key indicator of cancer spread
Results of a new Fox Chase Cancer Center study show that men with a rapidly rising PSA level before treatment have a high probability of metastatic disease and should receive hormone therapy in addition to radiation. view more (2006-11-09)
|
|
| Page
4 of
53 |
1057 Results |
|
|
|
Sort By:
Page Views | Date |
|
